Institutional Pediatric Convulsive Status Epilepticus Protocol Decreases Time to First and Second Line Anti-Seizure Medication Administration

被引:9
|
作者
Trau, Steven P. [1 ]
Sterrett, Emily C. [2 ]
Feinstein, Lydia [3 ,4 ]
Linh Tran [5 ]
Gallentine, William B. [6 ]
Tchapyjnikov, Dmitry [5 ]
机构
[1] Univ North Carolina Chapel Hill, Dept Neurol, Chapel Hill, NC USA
[2] Duke Univ, Dept Pediat, Div Emergency Med, Durham, NC 27706 USA
[3] Social & Sci Syst, Durham, NC USA
[4] Univ North Carolina Chapel Hill, Dept Epidemiol, Chapel Hill, NC USA
[5] Duke Univ, Dept Pediat, Div Neurol, Durham, NC 27706 USA
[6] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA
来源
关键词
status epilepticus; epilepsy; protocol; seizures; lorazepam; fosphenytoin; quality improvement; EMERGENCY MANAGEMENT; GUIDELINES; CHILDREN;
D O I
10.1016/j.seizure.2020.08.011
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose: Convulsive status epilepticus (CSE) is a medical emergency associated with high rates of morbidity and mortality. Although guidelines for CSE management recommend rapid treatment of seizures, prior studies show that compliance with these guidelines is low. In this study, we assessed if implementation of a paper-based clinical pathway for the treatment of CSE improves the timeliness and appropriate dosing of first and second line anti-seizure medications (ASM). Methods: A non-digital CSE treatment protocol was implemented as part of a quality improvement initiative in 2016. A retrospective analysis was subsequently conducted on cases of CSE originating in the pediatric emergency department (ED) from 2012-2019. Standard descriptive statistics were used to assess patient demographics as well as the timing and dosing of the first and second line ASMs used in our protocol (lorazepam [LZP] and fosphenytoin [FOS]). Statistical process control charts (XmR charts) were used to assess the variation in time to drug administration before and after implementation of the protocol. Results: 153 cases of CSE were identified (72 prior to and 81 after protocol implementation). Among patients who were actively having seizures on arrival to the ED (n = 44), the median time from arrival to ASM administration decreased from 15 to 11 minutes for the first LZP dose (p = 0.23), 23 to 10 minutes for the second LZP dose (p = 0.06), and 40 to 25 minutes for the PHE dose (p = 0.04). There was no improvement in time to LZP administration after seizure onset among those with seizure onset after hospital arrival (5 minutes before/after implementation for the first LZP dose and 15 to 14 minutes for second LZP dose); however, the time to FOS decreased from 42 to 22 minutes (p = 0.86). Statistical process control charts showed a universal decrease in variation for time to each drug administration after protocol implementation. Whereas FOS dosing was largely appropriate before and after protocol implementation, appropriate dosing of LZP did not improve, with only about half of patients receiving the recommended dose. Conclusion: The implementation of a paper-based treatment protocol for CSE was associated with a decreased time to ASM administration among patients who arrived to the ED, particularly for the second-line ASM. Approaches for improving appropriate benzodiazepine dosing are needed.
引用
收藏
页码:263 / 268
页数:6
相关论文
共 27 条
  • [1] Is Levetiracetam a Superior Anti-Seizure Medication in Pediatric Status Epilepticus?
    Iyer, Anand S.
    [J]. INDIAN PEDIATRICS, 2023, 60 (08) : 617 - 618
  • [2] Is Levetiracetam a Superior Anti-Seizure Medication in Pediatric Status Epilepticus?
    Anand S. Iyer
    [J]. Indian Pediatrics, 2023, 60 : 617 - 618
  • [3] Emergency First-Line Anti-Seizure Medication for Seizures and Status Epilepticus: What is Going Wrong, Doctor?
    Sutter, Raoul
    [J]. CNS DRUGS, 2018, 32 (10) : 891 - 893
  • [4] Emergency First-Line Anti-Seizure Medication for Seizures and Status Epilepticus: What is Going Wrong, Doctor?
    Raoul Sutter
    [J]. CNS Drugs, 2018, 32 : 891 - 893
  • [5] Treatment of status epilepticus in poststroke epilepsy with last generation anti-seizure medication
    Winter, Y.
    Sandner, K.
    Groppa, S.
    [J]. EPILEPSIA, 2022, 63 : 24 - 24
  • [6] IV LIDOCAINE: A SECOND LINE DRUG THERAPY FOR PEDIATRIC CONVULSIVE STATUS EPILEPTICUS?
    Fallah, R.
    [J]. IRANIAN JOURNAL OF CHILD NEUROLOGY, 2007, 1 (04) : 47 - 51
  • [7] Survey About Second-Line Agents for Pediatric Convulsive Status Epilepticus
    Tyson, Marguerite
    Trenear, Rebecca
    Skellett, Sophie
    Maconochie, Ian
    Mullen, Niall
    [J]. PEDIATRIC EMERGENCY CARE, 2023, 39 (04) : 247 - 252
  • [8] Benzodiazepine administration patterns before escalation to second-line medications in pediatric refractory convulsive status epilepticus
    Sheehan, Theodore
    Amengual-Gual, Marta
    Vasquez, Alejandra
    Abend, Nicholas S.
    Anderson, Anne
    Appavu, Brian
    Arya, Ravindra
    Aguilar, Cristina Barcia
    Brenton, J. Nicholas
    Carpenter, Jessica L.
    Chapman, Kevin E.
    Clark, Justice
    Farias-Moeller, Raquel
    Gaillard, William D.
    Gainza-Lein, Marina
    Glauser, Tracy A.
    Goldstein, Joshua L.
    Goodkin, Howard P.
    Guerriero, Rejean M.
    Huh, Linda
    Jackson, Michele
    Kapur, Kush
    Kahoud, Robert
    Lai, Yi-Chen
    McDonough, Tiffani L.
    Mikati, Mohamad A.
    Morgan, Lindsey A.
    Novotny, Edward J.
    Ostendorf, Adam P.
    Payne, Eric T.
    Peariso, Katrina
    Piantino, Juan
    Reece, Latania
    Riviello, James J.
    Sands, Tristan T.
    Sannagowdara, Kumar
    Shellhaas, Renee
    Smith, Garnett
    Tasker, Robert C.
    Tchapyjnikov, Dmitry
    Topjian, Alexis A.
    Wainwright, Mark S.
    Wilfong, Angus
    Williams, Korwyn
    Zhang, Bo
    Loddenkemper, Tobias
    [J]. EPILEPSIA, 2021, 62 (11) : 2766 - 2777
  • [9] Outcomes of the second withdrawal of anti-seizure medication in patients with pediatric-onset epilepsy
    Cho, Jaeso
    Kim, Hunmin
    Chae, Jong Hee
    Kim, Ki Joong
    Lim, Byung Chan
    [J]. EPILEPSIA, 2023, 64 (06) : E93 - E97
  • [10] Alert Protocol Reduces Time to Administration of Second-Line Antiseizure Medications for Status Epilepticus
    Clay, Jordan
    Villamar, Mauricio
    Bensalem-Owen, Meriem
    Goldstein, Larry
    Dolbec, Katelyn
    Cook, Aaron
    Ward-Mitchell, Rachel
    Ke, Chenlu
    Xu, Yan
    [J]. ANNALS OF NEUROLOGY, 2018, 84 : S186 - S186